Revenue
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | €3.06B | €3.26B | €3.06B | €3.00B | — | — | — |
| Research & development | — | — | — | — | €100,000 | €2.6M | €17.4M |
| Operating expenses | €197.7M | €203.2M | €231.2M | €242.8M | — | — | — |
| Operating income | €1.78B | €1.84B | €1.65B | €1.64B | −€465.7M | −€6.96B | €781.8M |
| Operating margin | 58.11% | 56.60% | 53.94% | 54.70% | — | — | — |
| EBITDA | €2.72B | €1.63B | −€727.3M | €1.10B | −€432.8M | −€6.95B | €783.8M |
| EBITDA margin | 89.07% | 49.96% | −23.76% | 36.72% | — | — | — |
| Net income | €1.51B | €278.2M | −€1.78B | €288.5M | −€991.3M | −€7.67B | €1.11B |
| Net profit margin | 49.28% | 8.54% | −58.11% | 9.60% | — | — | — |
| Basic EPSper basic share | €8.86 | €1.05 | -€11.72 | €1.28 | -€7.02 | -€52.10 | €7.97 |
| Diluted EPSper diluted share | €8.72 | €1.04 | -€11.72 | €1.28 | -€7.02 | -€52.10 | €7.91 |